AbbVie Inc. is 10.2x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($399.47 B vs $39.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TEVA | ABBV |
|---|---|---|
| Market cap | $39.12 B | $399.47 B |
| US-listed rank | #392 | #28 |
| Revenue (latest FY) | $17.26B | $61.16B |
| Net income (latest FY) | $1.41B | $4.23B |
| Net margin | 8.2% | 6.9% |
| P/E (trailing FY) | 27.7 | 94.5 |
| SEC filings | 2,473 | 1,008 |
AbbVie Inc. is 10.2x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($399.47 B vs $39.12 B).
In their latest fiscal years, TEVA PHARMACEUTICAL INDUSTRIES LTD reported $17.26B in revenue while AbbVie Inc. reported $61.16B.
Full pages: TEVA PHARMACEUTICAL INDUSTRIES LTD and AbbVie Inc., or browse the full rankings.